Riskpilot← Back to searchSign inGet full accessMedvilja AB
ABActiveOrg 5593025538Göteborgsvägen 23 1 TrConstruction of residential and non-residential buildings · NACE 4100Est. 20210 employees
Revenue 2024
SEK 13,1M
-7% vs 2023
EBITDA margin
10.2%
+1529% vs 2023
Equity ratio
7.8%
Financial strength
Net profit 2024
SEK 820K
+963% vs 2023
| Revenue | SEK 13,1M | -7% |
| EBITDA | SEK 1,3M | +1529% |
| Net profit | SEK 820K | +963% |
| Total assets | SEK 10,9M | +58% |
| Equity | SEK 857K | +2279% |
| Employees | 0 | — |
Legal name
Medvilja AB
Org number
5593025538
Legal form
Aktiebolag
NACE code
4100 · Construction of residential and non-residential buildings
Founded
17 februari 2021
Share capital
SEK 25 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska bedriva byggnadsverksamhet samt äga och förvalta fastigheter samt därmed förenlig verksamhet.
Address
Göteborgsvägen 23 1 Tr
Email
mats@talang.nu
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Revenue | 50 474 | 42 272 | 14 063 | 13 072 |
| Staff expenses | — | — | — | — |
| EBITDA | 2 843 | 1 715 | −93 | 1 329 |
| Depreciation & amort. | −0 | −0 | −0 | — |
| EBIT | 2 843 | 1 715 | −93 | 1 329 |
| Net financials | — | −2 | −2 | −10 |
| Profit before tax | 2 142 | 2 413 | −95 | 1 011 |
| Tax | −441 | −498 | −0 | −191 |
| Net profit | 1 701 | 1 915 | −95 | 820 |
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Total assets | 18 643 | 5 406 | 6 901 | 10 916 |
| Equity | 1 726 | 2 391 | 36 | 857 |
| Long-term debt | 0 | 0 | 0 | — |
| Short-term debt | 16 217 | 3 015 | 6 864 | 9 751 |
| Total debt | 16 217 | 3 015 | 6 864 | 9 751 |
EBITDA margin
10.2%
This company
15.8%
Market median
-35% vs market
20212024
Equity ratio
7.8%
This company
38.2%
Market median
-80% vs market
20212024
Return on equity
95.8%
This company
18.4%
Market median
+421% vs market
20212024
Net profit margin
6.3%
This company
8.1%
Market median
-22% vs market
20212024
Asset turnover
1.20×
This company
1.12×
Market median
+7% vs market
20212024
Debt / equity
11.74×
This company
0.62×
Market median
-1794% vs market
20212024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-02-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
ML Chief Executive Officer | Chief Executive Officer | 2022 |
| Former (1) | ||
EC | Audit | 2022 – 2024 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2021 | |
| Former (1) | ||
| Board of Directors | 2022 – 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Winnervalley AB
Medvilja AB Board members of Medvilja AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Eva Chris Nettervik Carlsson | Audit | 0 companies |
| Mats Leif Segerdahl | Chief Executive Officer | 0 companies |
| Marie Gisela Wallin | Deputy Board Member | 0 companies |
| Berndt Rickard Johansson | Board of Directors | 0 companies |